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POLICY
BRIEF

May 2014

REDUCING UNSAFE MENSTRUAL REGULATION
THROUGH MEDICATION IN BANGLADESH
Despite the availability of effective modern
contraceptive methods in Bangladesh, the
number of unsafe menstrual regulations
is increasing each year, resulting in
increased risk of maternal morbidity.
Menstrual regulation (MR) is a medical method of
safely establishing non-pregnancy after a missed
period. In Bangladesh, MR is typically conducted
using manual vacuum aspiration (MVA). In 2010,
approximately 653,000 MRs were performed in
Bangladesh.
STEP UP generates
policy-relevant research
to promote an evidencebased approach for
improving access to
family planning and
safe abortion.

However, MR using MVA carries both health and
social risks:

We work in Bangladesh,
northern India, Ghana,
Kenya, and Senegal.
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Stigma and the fear of their situation being
disclosed to their community often lead women to
turn to illegal measures for abortions that are
ineffective, harmful, and life-threatening.
Studies suggest that unsafe MVA performed by
unskilled providers in unhygienic conditions
results in over one-third of women suffering postMVA complications.
Statistics from selected NGO facilities that
provide postabortion care services indicate that
25–48% of women who visited these facilities
requested treatment for post-MVA
complications (Causes included poor service
quality, lack of infection control, and unskilled
individuals providing unsafe MVA).

Why is Menstrual Regulation through
Medication important?
Menstrual Regulation with Medication (MRM) is a
non-invasive, safe alternative to MVA that is approved
in Bangladesh but not yet widely available. By
increasing access to this simple and safe MR option,
women’s morbidity due to MR in Bangladesh could be
significantly decreased.

CONCLUSIONS
 It is feasible and safe to
introduce Menstrual
Regulation with Medication in
Bangladesh.
 Women receiving MRM were
satisfied with their quality of
care.

RECOMMENDATIONS
The Ministry of Health and
Family Welfare, along with its
partners, must:
 In preparation for introducing
MRM nationwide, plan a
scale-up strategy for phasing
in services.
 Implement services first in
urban health facilities such as
Maternal and Child Welfare
Centres (MCWCs) and
gradually expand to rural
areas.
 Simultaneously, implement a
comprehensive training
program to train all public
sector MR service providers.
 Provide adequate supervision
so as to ensure the quality of
services.
 Revise and update the
management information
system to include MRM
information.
 Ensure that the requisite
medications are routinely
supplied to all facilities
providing MRM services.

About this study
The Population Council and Marie Stopes
Bangladesh, in collaboration with the Directorate
General of Family Planning and with funding from the
World Health Organisation, tested the feasibility of
introducing MRM in Bangladesh and assessed the
acceptability of providing MRM using the combination
drug regimen Mifepristone and Misoprostol in urban
and rural public health facilities.
An 18-month operations research study was conducted
from January 2012 to June 2013. Health facilities were
selected with high numbers of MR clients and available
trained service providers. All women who visited the 13
health facilities for MR services between October 2012
and May 2013 were invited to participate in the study.
All women were counseled by trained service providers
about the advantages, disadvantages, and side effects of
MR and given a choice between MVA and MRM to
regulate menstruation. Clients selecting MRM had the
option of taking the second dose—Misoprostol 800mcg—
at the health facility or at home after 24–48 hours.


Of the 2,976 women who visited the health facilities
seeking MR services 63 percent (1,882) selected
MRM services.



Using simple random sampling, information was
collected from 836 MRM acceptors and 44 service
providers to assess the feasibility and outcomes of
the procedure.



Women who self-administered the second dose were
educated on the correct technique for taking the drug,
possible side effects, and were given clear
instructions to return to the facility or seek immediate
medical attention from the call center if they
experienced heavy or prolonged vaginal bleeding,
sever cramping, fever, chills or malaise lasting more
than six hours, any abnormal vaginal discharge,
severe abdominal pain, or nausea.



Women were asked to return to the facility within
10–14 days after taking the second dose for a
bimanual pelvic examination to confirm completeness
of the MRM procedure.

Results










Nearly all providers determined the last menstrual
period and 70 percent took a menstrual history. The
overall quality of services provided at these health
facilities was high.
Almost all MRM acceptors (97 percent) reported that
they would suggest MRM to their friends and relatives;
95 percent would refer a friend to the same facility.
The vast majority (92%) of women returned to the
facility for the examination to confirm procedure
completion.
One in five clients experienced a side effect
(commonly nausea) after taking Mifepristone (first
dose), although less than half of these women
required medication or further treatment for the side
effect.
Of the 71 women (5%) who experienced incomplete
MRM, 59 received MVA and 12 were referred for
dilation and curettage (D&C) services to complete the
procedure.
The most frequently discussed contraceptive methods
during follow-up visits were oral contraceptive pills
(77%) followed by IUDs and condoms. Findings
suggest that 69 percent of MRM clients accepted oral
pills and 12 percent did not accept any form
contraception while 19 percent selected other shortacting methods.

Conclusions
This study demonstrates that is feasible and safe to
introduce MRM in Bangladesh in rural and urban public
health facilities. Given the choice, almost two-thirds of
women preferred MRM to MVA and women receiving
MRM reported being satisfied or very satisfied with their
quality of care. It is recommended that the Ministry of
Health and Family Welfare (MOHFW) and its partners
work together to train providers and to procure the medical
commodities to introduce MRM as an option for menstrual
regulation in health facilities nationwide.
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